March 25, 2020 / 7:41 PM / 8 days ago

BRIEF-Relief Therapeutics Says Co And Neurorx Inc File FDA IND For Aviptadil To Treat Covid-19-Induced Respiratory Distress

March 25 (Reuters) - RELIEF THERAPEUTICS :

* RELIEF THERAPEUTICS SAYS CO AND NEURORX INC FILE FDA IND FOR AVIPTADIL TO TREAT COVID-19-INDUCED RESPIRATORY DISTRESS

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below